Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bloom syndrome].

N Kondo1

  • 1Department of Pediatrics, Gifu University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 2, 2000
PubMed
Summary
This summary is machine-generated.

Bloom syndrome (BS) is a rare genetic disorder caused by mutations in the BLM gene, leading to increased cancer risk. The BLM gene encodes a DNA helicase crucial for genomic stability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of muscle mass on V(O(2)) kinetics at the onset of work.

Journal of applied physiology (Bethesda, Md. : 1985)·2001
Same author

The clinical phenotype and outcome of mitochondrial acetoacetyl-CoA thiolase deficiency (beta-ketothiolase or T2 deficiency) in 26 enzymatically proved and mutation-defined patients.

Molecular genetics and metabolism·2001
Same author

Fate of the mutated IgG2 heavy chain: lack of expression of mutated membrane-bound IgG2 on the B cell surface in selective IgG2 deficiency.

International immunology·2001
Same author

Myopathic form of very-long chain acyl-coa dehydrogenase deficiency: evidence for temperature-sensitive mild mutations in both mutant alleles in a Japanese girl.

Pediatric research·2001
Same author

Long-term study of a female hyper-IgM immunodeficiency.

Experimental and clinical immunogenetics·2000
Same author

[Pharmacological properties of nateglinide, rapid-onset/short-duration insulinotropic agent, in the treatment of type 2 diabetes].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2000
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Biology
  • Biochemistry

Context:

  • Bloom syndrome (BS) is a rare autosomal recessive disorder.
  • Characterized by growth retardation, sun sensitivity, immune deficiency, and a high risk of diverse cancers.
  • The BLM gene, encoding a DNA helicase, is identified as the causative gene for BS.

Purpose:

  • To elucidate the role of the BLM gene and its protein product in Bloom syndrome.
  • To understand the molecular mechanisms underlying the predisposition to cancer in BS patients.
  • To explore the function of the BLM protein as an ATP-dependent DNA helicase.

Summary:

  • The BLM gene encodes a 1417 amino acid peptide homologous to ATP-dependent DNA helicases, belonging to the RecQ helicase family.

Related Experiment Videos

  • DNA helicases are vital enzymes that unwind double-stranded DNA, facilitating replication, repair, recombination, and transcription.
  • The BLM protein localizes to the nucleus, with specific C-terminal residues essential for nuclear targeting, and its dysfunction is linked to cancer.
  • Impact:

    • Provides insights into the genetic basis of Bloom syndrome and its associated cancer predisposition.
    • Highlights the critical role of the BLM helicase in maintaining genomic stability.
    • Contributes to understanding DNA repair pathways and their implications in oncogenesis.